Literature DB >> 7134745

Diclofenac sodium, diflunisal and naproxen: patient preferences for anti-inflammatory drugs in rheumatoid arthritis.

E C Huskisson, P A Dieppe, J Scott, H Jones.   

Abstract

Ninety patients with active rheumatoid arthritis took part in a cross-over trial comparing diclofenac sodium, diflunisal and naproxen. The efficacy of the three drugs was similar though there were trends in favour of diclofenac sodium in some measurements. The incidence of side-effects was similar with the three drugs and each was chosen by a significant group of patients as continuation therapy at the end of the study.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7134745     DOI: 10.1093/rheumatology/21.4.238

Source DB:  PubMed          Journal:  Rheumatol Rehabil        ISSN: 0300-3396


  4 in total

Review 1.  Variability in response to NSAIDs. Fact or fiction?

Authors:  R O Day; G G Graham; K M Williams; P M Brooks
Journal:  Drugs       Date:  1988-12       Impact factor: 9.546

2.  Clinical pharmacology of GP53,633--a new non-steroidal anti-inflammatory drug--in patients with rheumatoid arthritis.

Authors:  S Wanwimolruk; D Thomas; D J Birkett; J O Miners; P M Brooks
Journal:  Agents Actions       Date:  1984-10

3.  A comparison of diflunisal and phenylbutazone in the treatment of ankylosing spondylitis.

Authors:  M J Franssen; F W Gribnau; L B van de Putte
Journal:  Clin Rheumatol       Date:  1986-06       Impact factor: 2.980

Review 4.  Diclofenac sodium. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  P A Todd; E M Sorkin
Journal:  Drugs       Date:  1988-03       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.